Feng Z - Search Results

1

Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold.

Chen H, Wang K, Yang Y, Huang X, Dai X, Feng Z. Chen H, et al. Among authors: feng z. Eur J Med Chem. 2021 May 5;217:113377. doi: 10.1016/j.ejmech.2021.113377. Epub 2021 Mar 15. Eur J Med Chem. 2021. PMID: 33770574

2

Acryloylamino-salicylanilides as EGFR PTK inhibitors.

Deng W, Guo Z, Guo Y, Feng Z, Jiang Y, Chu F. Deng W, et al. Among authors: feng z. Bioorg Med Chem Lett. 2006 Jan 15;16(2):469-72. doi: 10.1016/j.bmcl.2005.06.088. Epub 2005 Nov 3. Bioorg Med Chem Lett. 2006. PMID: 16275081

3

Synthesis and anti-inflammatory activity of the major metabolites of imrecoxib.

Feng Z, Chu F, Guo Z, Sun P. Feng Z, et al. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2270-2. doi: 10.1016/j.bmcl.2009.02.090. Epub 2009 Feb 27. Bioorg Med Chem Lett. 2009. PMID: 19286379

4

[Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety].

Qin AF, Li Y, Song HR, Chen XG, Jin XF, Wang K, Zhang LJ, Huo LC, Feng ZQ. Qin AF, et al. Yao Xue Xue Bao. 2012 Dec;47(12):1623-9. Yao Xue Xue Bao. 2012. PMID: 23460968 Chinese.

5

Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPARγ.

Li Y, Tian K, Qin A, Zhang L, Huo L, Lei L, Shen Z, Song H, Feng Z. Li Y, et al. Among authors: feng z. Eur J Med Chem. 2014 Apr 9;76:182-92. doi: 10.1016/j.ejmech.2014.02.024. Epub 2014 Feb 11. Eur J Med Chem. 2014. PMID: 24583379

6

[Synthesis and in vitro cytotoxic activities of sorafenib derivatives].

Wang K, Li Y, Zhang LJ, Yang HZ, Chen XG, Feng ZQ. Wang K, et al. Yao Xue Xue Bao. 2014 May;49(5):639-43. Yao Xue Xue Bao. 2014. PMID: 25151734 Chinese.

7

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.

Zhou C, Lai F, Sheng L, Chen X, Li Y, Feng Z. Zhou C, et al. Among authors: feng z. Molecules. 2020 Mar 23;25(6):1447. doi: 10.3390/molecules25061447. Molecules. 2020. PMID: 32210078 Free PMC article.

8

Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction.

Yang Y, Wang K, Chen H, Feng Z. Yang Y, et al. Among authors: feng z. Eur J Med Chem. 2021 Feb 5;211:113001. doi: 10.1016/j.ejmech.2020.113001. Epub 2020 Nov 10. Eur J Med Chem. 2021. PMID: 33272783

9

Design, synthesis, and biological evaluation of 1-methyl-1H-pyrazolo[4,3-b]pyridine derivatives as novel small-molecule inhibitors targeting the PD-1/PD-L1 interaction.

Dai X, Wang K, Chen H, Huang X, Feng Z. Dai X, et al. Among authors: feng z. Bioorg Chem. 2021 Sep;114:105034. doi: 10.1016/j.bioorg.2021.105034. Epub 2021 May 30. Bioorg Chem. 2021. PMID: 34116264

10

Design, synthesis, and structure-activity relationship of PD-1/PD-L1 inhibitors with a benzo[d]isoxazole scaffold.

Huang X, Chen H, Dai X, Xu M, Wang K, Feng Z. Huang X, et al. Among authors: feng z. Bioorg Med Chem Lett. 2021 Nov 15;52:128403. doi: 10.1016/j.bmcl.2021.128403. Epub 2021 Oct 2. Bioorg Med Chem Lett. 2021. PMID: 34610423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,286 results

Search Page

Filters